Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biologic basis for combining drugs with radiation.

George D Wilson1, Søren M Bentzen, Paul M Harari

  • 1Department of Radiation Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.

Seminars in Radiation Oncology
|December 28, 2005
PubMed
Summary

Concurrent cancer treatments like radiation and chemotherapy are common, but their interaction mechanisms are still being explored. Research shows how cisplatin, 5-fluorouracil (5-FU), and gemcitabine affect DNA repair and cell cycles, impacting radiosensitization.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Low-Energy Virtual Monoenergetic Images Derived From Dual-Energy Computed Tomography in Tumor Segmentation for Head and Neck Radiation Therapy: A Contouring Study.

Advances in radiation oncology·2026
Same author

A Head and Neck Cancer Patient-Specific Microphysiological System for Predicting Response to Chemoradiation.

bioRxiv : the preprint server for biology·2026
Same author

Integrated Single-Cell and Spatial Analysis Reveals Context-Dependent Myeloid-T Cell Interactions in Response to Immune Checkpoint Blockade in Head and Neck Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Quality of Life in Patients With p16+ Oropharyngeal Cancer Receiving Accelerated Radiation Therapy With Either Cisplatin or Cetuximab in the NRG/RTOG 1016 Randomized Controlled Trial.

International journal of radiation oncology, biology, physics·2026
Same author

STING predicts patterns of failure in locally advanced head and neck squamous cell carcinoma.

JNCI cancer spectrum·2026
Same author

Pretreatment Chromosomal Instability Correlates With Radiation Sensitivity in Squamous Cell Cancers.

International journal of radiation oncology, biology, physics·2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiation Oncology

Background:

  • Concurrent radiation and chemotherapy is a primary cancer treatment modality.
  • The precise mechanisms of interaction between radiation and chemotherapy require further elucidation.

Purpose of the Study:

  • To explore the evolving understanding of drug-radiation interactions in cancer therapy.
  • To detail how specific chemotherapeutic agents influence radiation-induced DNA damage and repair pathways.

Main Methods:

  • Review of biological evidence from experimental cell lines and tumors.
  • Analysis of the impact of cisplatin, 5-fluorouracil (5-FU), and gemcitabine on DNA repair and cell cycle progression.

Main Results:

Related Experiment Videos

  • Cisplatin inhibits repair of radiation-induced DNA damage, affecting homologous recombination and nonhomologous end joining.
  • 5-FU causes radiosensitization through aberrant S-phase progression, impacting DNA repair and cell cycle.
  • Gemcitabine induces radiosensitization by depleting nucleotide pools, leading to DNA misincorporation and misrepair in irradiated cells.

    • Conclusions:

    • Understanding drug-radiation interactions is crucial for optimizing cancer treatment.
    • New molecular-targeted agents necessitate innovative approaches to drug-radiation cooperation and clinical trial design.